RIVM European Reference Lab for vector-borne infections The European Commission (EC) has designated RIVM as the current European Reference Lab (EURL) for vector-borne viral pathogens.
Last chance for young adults to get vaccinated against HPV for free Today sees the launch of the ‘Do not miss out’ campaign, which calls on young people to get the first dose of the vaccine against the human papillomavirus (HPV) as soon as possible.
RIVM publishes new data from manufacturers on tobacco products On behalf of the Dutch Ministry of VWS (Health, Welfare and Sport), RIVM has published new data on tobacco products. For the first time, these data include the ingredients of e-cigarettes, heated tobacco products and herbal smoking products.
Vaccination rate again drops slightly, HPV vaccination rate drops considerably The vaccination rate for vaccines included in the National Immunisation Programme has dropped slightly by about 1 percent.
RIVM measures much higher levels of tar, nicotine and carbon monoxide in cigarettes Tar, nicotine and carbon monoxide (TNCO) levels measured in accordance with the Canadian Intense (CI) method are at least twice as high as the levels measured in accordance with the prescribed ISO
One Health European Joint Programme (EJP) Expert Meeting On the 4th and 5th of June 2018, an expert meeting was held at RIVM to redefine and prioritise the topics for One Health research and integrative activities in Europe.